Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Bacteriology|July 18, 2003
IS981-mediated adaptive evolution recovers lactate production by ldhB transcription activation in a lactate dehydrogenase-deficient strain of Lactococcus lactisRoger S Bongers, Marcel H N Hoefnagel, Marjo J C Starrenburg, et al.Vaccine|August 1, 2023
Variability of in vivo potency assays of whole-cell pertussis, inactivated polio, and meningococcal B vaccinesCerissa van Walstijn, Stefan Verweij, Rory Care, et al.Vaccine|April 7, 2021
Variability of in vivo potency tests of Diphtheria, Tetanus and acellular Pertussis (DTaP) vaccinesCoen A L Stalpers, Irene A Retmana, Jeroen L A Pennings, et al.Microbiology (Reading, England)|April 5, 2002
Metabolic engineering of lactic acid bacteria, the combined approach: kinetic modelling, metabolic control and experimental analysisMarcel H N Hoefnagel, Marjo J C Starrenburg, Dirk E Martens, et al.Expert Review of Vaccines|September 22, 2021
Overcoming scientific barriers in the transition from in vivo to non-animal batch testing of human and veterinary vaccinesRobin H G A van den Biggelaar, Marcel H N Hoefnagel, Rob J Vandebriel, et al.Cytotherapy|February 17, 2021
Estimation of manufacturing development costs of cell-based therapies: a feasibility studyRenske M T Ten Ham, Julianne C Nievaart, Jarno Hoekman, et al.Cytotherapy|May 17, 2020
What does cell therapy manufacturing cost? A framework and methodology to facilitate academic and other small-scale cell therapy manufacturing costingsRenske M T Ten Ham, Anke M Hövels, Jarno Hoekman, et al.Pageof 2